Ironwood Pharmaceuticals, Inc.
IRWD
$4.31
$0.235.64%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 117.34% | 209.06% | -200.89% | 999.29% | 2,844.07% |
| Total Depreciation and Amortization | -2.14% | -7.52% | -5.15% | -6.31% | -7.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.52% | 249.43% | -93.70% | 92.36% | -14.25% |
| Change in Net Operating Assets | 78.32% | -219.43% | 315.98% | -128.61% | -632.41% |
| Cash from Operations | 486.75% | -74.34% | 390.17% | 381.37% | -145.03% |
| Capital Expenditure | -- | -- | -- | 87.50% | 96.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 87.50% | 96.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 244.32% | -- | -39.90% | -- | -88.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -227,028.41% | -- | 100.82% | 100.00% | 100.18% |
| Foreign Exchange rate Adjustments | 111.90% | -1,414.29% | 1,571.43% | 0.00% | -1,168.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -804.37% | -74.83% | 21,465.80% | 374.68% | 2.42% |